ASX - Delayed Quote
AUD
Cyclopharm Limited (CYC.AX)
0.4250
+0.0400
(+10.39%)
At close: October 30 at 4:10:11 PM GMT+11
Loading chart for CYC.AX
- Previous Close
0.3850 - Open
0.4000 - Bid 0.4250 x --
- Ask 0.4500 x --
- Day's Range
0.4000 - 0.4550 - 52 Week Range
0.3300 - 1.2900 - Volume
111,297 - Avg. Volume
68,525 - Market Cap (intraday)
53.437M - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1600 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date Sep 1, 2023
- 1y Target Est
1.02
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
CYC.AX
56.63%
S&P/ASX 200 [XJO] (^AXJO)
2.22%
1-Year Return
CYC.AX
33.07%
S&P/ASX 200 [XJO] (^AXJO)
0.29%
3-Year Return
CYC.AX
78.43%
S&P/ASX 200 [XJO] (^AXJO)
31.37%
5-Year Return
CYC.AX
78.39%
S&P/ASX 200 [XJO] (^AXJO)
21.63%
Analyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-53.23%
-
Return on Assets (ttm)
-20.30%
-
Return on Equity (ttm)
-53.92%
-
Revenue (ttm)
34.42M
-
Net Income Avi to Common (ttm)
-18.32M
-
Diluted EPS (ttm)
-0.1600
Balance Sheet and Cash Flow
-
Total Cash (mrq)
12.25M
-
Total Debt/Equity (mrq)
24.49%
-
Levered Free Cash Flow (ttm)
-9.63M
